TITLE

Optimization of Liver Transplantation as a Treatment of Intrahepatic Hepatocellular Carcinoma Recurrence After Partial Liver Resection: Experience of a Single European Series

AUTHOR(S)
Sapisochin, Gonzalo; Bilbao, Itxarone; Balsells, Joaquin; Dopazo, Cristina; Caralt, Mireia; Lázaro, Jose; Castells, Luis; Allende, Helena; Charco, Ramón
PUB. DATE
September 2010
SOURCE
World Journal of Surgery;Sep2010, Vol. 34 Issue 9, p2146
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
The aim of this study was to ascertain the outcome of liver transplantation (LT) due to hepatocellular carcinoma (HCC) in patients who had undergone previous liver resection (LR) for HCC. A case-control study (1:2) was designed to compare patients who underwent LT due to HCC recurrence with a previous LR for HCC (study group) with those who underwent LT for primary HCC but without previous LR (control group). From January 1990 to December 2007, a total of 303 cirrhotic patients with primary HCC were evaluated for surgery. Primary LT was performed in 191 and LR in 100. When HCC recurrence was diagnosed after LR (69/100), 17 of the 69 (25%) patients underwent LT (study group). The median follow-up was 70 months (12.7–203.0 months). Disease-free survivals at 1, 3, and 5 years in the study group versus the control group were 86%, 68%, 58% vs. 97%, 93%, 89%, respectively ( p < 0.04). The 1-, 3-, and 5-year actuarial patient survivals in the study group versus the control group were 59%, 52%, 52% vs. 85%, 76%, 65%, respectively ( p = NS). Patients of the study group were divided into two groups according to the time to recurrence after LR: group 1 was <1 year, and group 2 was >1 year. Recurrence after LT was 75% in group 1 vs. 15.4% in group 2 ( p < 0.03). The 1-, 3-, and 5-year actuarial patient survivals were 25%, 0%, 0% in group 1 and 69%, 69%, 69% in group 2, p < 0.02). Liver transplantation can be safely performed after a previous LR for HCC. Patients with recurrence during the first year after hepatectomy have a poor prognosis after LT.
ACCESSION #
52760311

 

Related Articles

  • Analysis of the recurrence risk factors for the patients with hepatocellular carcinoma meeting University of California San Francisco criteria after curative hepatectomy. Ruey-Shyang Soong; Ming-Chin Yu; Kun-Ming Chan; Hong-Shiue Chou; Ting-Jung Wu; Chen-Fang Lee; Tsung-Han Wu; Wei-Chen Lee // World Journal of Surgical Oncology;2011, Vol. 9 Issue 1, p9 

    The article presents information on the findings of a study that aims to identify patients who accepted hepatectomy for a tumor/tumors. The study analyzed the pre-operative data of the patients and attempt to find the pre-operative risk factors of HCC recurrence. The survival rates of the...

  • Prognostic Impact of Sarcomatous Change of Hepatocellular Carcinoma in Patients Undergoing Liver Resection and Liver Transplantation. Shin Hwang; Sung-Gyu Lee; Young-Joo Lee; Chul-Soo Ahn; Ki-Hun Kim; Kwang-Min Park; Ki-Myung Moon; Deok-Bog Moon; Tae-Yong Ha; Eun-Sil Yu; Ga-Won Choi // Journal of Gastrointestinal Surgery;Apr2008, Vol. 12 Issue 4, p718 

    Sarcomatous change has been rarely observed in hepatocellular carcinoma (HCC), but it is usually associated with very aggressive tumor behavior and widespread metastasis. To assess the impact of sarcomatous changes, we analyzed the outcomes of 15 patients with sarcomatous HCC after resection...

  • Surgical treatment of hepatocellular carcinoma in China. Chen, Xiao-Ping; Huang, Zhi-Yong // Langenbeck's Archives of Surgery;Jul2005, Vol. 390 Issue 3, p259 

    Background and aims: Surgery remains the most effective treatment for hepatocellular carcinoma (HCC). While resection and liver transplantation achieve the best out- comes in patients with small HCC, controversy surrounds treatment of large HCC, HCC with portal vein tumor thrombus, and HCC with...

  • Overexpression of ZEB2 in Peritumoral Liver Tissue Correlates with Favorable Survival after Curative Resection of Hepatocellular Carcinoma. Mu-Yan Cai; Rong-Zhen Luo; Jie-Wei Chen; Xiao-Qing Pei; Jia-Bin Lu; Jing-Hui Hou; Jing-Ping Yun // PLoS ONE;Feb2012, Vol. 7 Issue 2, p1 

    Background: ZEB2 has been suggested to mediate EMT and disease aggressiveness in several types of human cancers. However, the expression patterns of ZEB2 in hepatocellular carcinoma (HCC) and its effect on prognosis of HCC patients treated with hepatectomy are unclear. Methodology/Principal...

  • Intermittent Pringle Maneuver and Hepatic Function: Perioperative Monitoring by Noninvasive ICG-Clearance. Tralhão, José; Hoti, Emir; Oliveiros, Bárbara; Abrantes, Ana; Botelho, M.; Castro-Sousa, F. // World Journal of Surgery;Dec2009, Vol. 33 Issue 12, p2627 

    Background: Intermittent Pringle maneuver or selective portal clamping often are used to control inflow during parenchymal liver transection. This study was designed to determinate whether these maneuvers are associated with adverse hepatic function. Methods: Resection was performed without...

  • Integrative genomics identifies YY1AP1 as an oncogenic driver in EpCAM+ AFP+ hepatocellular carcinoma. Zhao, X; Parpart, S; Takai, A; Roessler, S; Budhu, A; Yu, Z; Blank, M; Zhang, Y E; Jia, H-L; Ye, Q-H; Qin, L-X; Tang, Z-Y; Thorgeirsson, S S; Wang, X W // Oncogene;9/24/2015, Vol. 34 Issue 39, p5095 

    Identification of key drivers and new therapeutic targets is important given the poor prognosis for hepatocellular carcinoma (HCC) patients, particularly those ineligible for surgical resection or liver transplant. However, the approach to identify such driver genes is facing significant...

  • Salvage Liver Transplantation for Patients with Recurrent Hepatocellular Carcinoma after Curative Resection. LinWei Wu; AnBin Hu; Ngalei Tam; JianWei Zhang; Min Lin; ZhiYong Guo; XiaoShun He // PLoS ONE;Jul2012, Vol. 7 Issue 7, p1 

    Objective: To summarize the experience with salvage liver transplantation (SLT) for patients with recurrent hepatocellular carcinoma (HCC) after primary hepatic resection in a single center. Methods: A total of 376 adult patients with HCC underwent orthotopic liver transplantation (OLT) at Organ...

  • Longer transplant waits for HCC patients may be beneficial.  // Hem/Onc Today;12/10/2013, Vol. 14 Issue 23, p23 

    The article discusses a research study which suggested the benefit of longer transplant waits for patients with hepatocellular carcinoma (HCC), presented at The Liver Meeting held in Washington on November 1-5, 2013.

  • Large hepatocellular cancers: hepatic resection or liver transplantation? Søreide, O.; Czerniak, A.; Blumgart, L.H. // British Medical Journal (Clinical Research Edition);9/28/1985, Vol. 291 Issue 6499, p853 

    Examines patients with primary hepatocellular cancer. Outline of criteria for resectability in patients with large liver tumors; Extension of the traditional criteria of resectability; Preference for resection than transplantation.

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics